The application of collaborative nursing model improve the postoperative pulmonary rehabilitation in patients with lung carcinoma: a retrospective study of 345 cases.

INTRODUCTION

Lung carcinoma is a leading cause of cancer-related mortality worldwide, and while surgical resection remains a primary treatment option, postoperative recovery often presents significant challenges, particularly in terms of pulmonary function and quality of life (QOL). The study aimed to evaluate the effectiveness of the Collaborative Nursing Model (CNM) in improving postoperative pulmonary rehabilitation.

METHODS

This retrospective study included 345 lung carcinoma patients who underwent surgical resection. Patients were divided into an intervention group (n = 248), which received postoperative care under the CNM, and a control group (n = 97), which received standard postoperative care. Outcomes assessed included pulmonary function recovery, rehabilitation adherence, QOL, postoperative complications, and psychological wellbeing.

RESULTS

The intervention group showed greater improvements in pulmonary function compared with the control group, including FVC (1 +6.0%, 95% CI 3.6-8.4), FEV1 (1 +5.9%, 95% CI 3.4-8.4), and MVV (1 +4.93 L/min, 95% CI 3.4-6.5). Rehabilitation adherence (84.8% vs. 62.3%; RD +22.5%, 95% CI 12.1-32.9%) and dietary adherence (88.3% vs. 70.4%; RD +17.9%, 95% CI 7.8-28.0%) were higher in the intervention group. Greater improvements were also observed in quality of life, with larger reductions in SGRQ scores (1 -7.44, 95% CI -10.2 to -4.7) and increases in SF-36 scores (1 +7.94, 95% CI 5.7-10.2). The incidence of pulmonary infections was lower in the intervention group (8.2% vs. 17.3%; RD -9.1%, 95% CI -17.8 to -0.4), while differences in other complications were not statistically significant. Psychological outcomes were improved, with greater reductions in anxiety and depression scores (both 1 -1.97, 95% CI -3.0 to -1.0).

DISCUSSION: The CNM was associated with improved postoperative pulmonary rehabilitation outcomes in lung cancer patients, including better pulmonary function, higher adherence, improved QOL, and a lower incidence of complications and psychological distress.